Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Conclusion: Disclosure of interest: All authors: nothing to disclose E-Posters - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.01 - ACUTE MANAGEMENT - Neither thrombolysis nor thrombectomy P2131 - ESOC25-2296 MANAGEMENT OF TIA AND STROKE ATTACK RISK STRATIFICATION: EXPERIENCE IN AN ALGERIAN PERIPHERAL HOSPITAL Amina Behiri 1 , Sonia Nouioua 1 , Feroudja Ramdane Cherif 1 1 Department of Neurology El Maham, cherchell, Algeria Background and Aims: The aim of our study is to evaluate the management efficiency for TIA in an Algerian peripheral hospital, and to analyze the risk factors associated with outcome to an ischemic stroke
Zupo R, Castellana F, Sardone R, Lampignano L, Di Noia C, Savastano S, Giannelli G, De Pergola G
Theoretical risk exists for accelerating existing cancers
Men using physician-supervised peptide therapy report improved mood, better sexual function, and renewed motivation for training and life goals-changes that compound over months and years
The Ac-SDKP Fragment and Derivative Studies Beyond thymosin beta-4 and TB-500, the tetrapeptide fragment Ac-SDKP (acetyl-seryl-aspartyl-lysyl-proline), also known as goralatide, represents another bioactive derivative of the thymosin family
This non-invasive method was chosen to minimize stress associated with handling or injection, allowing fish to be subjected to the substance without additional confounding factors
